Furthermore, other studies reported that CCNF (an E3 ligase) targets RRM2 (Ribonucleotide reductase M2), a pro-tumorigenic protein, which is linked to poor survival rate in patients with skin melanoma and associated with its protein degradation activity [22]. The gene discussed is RRM2; the disease is cutaneous melanoma.